§ Research summary · Nootropic

Semax 11 mg

Also known as · ACTH(4-7)-Pro-Gly-Pro

Nootropic·1 min read·reviewed 2026-05-07

Semax is a synthetic heptapeptide analogue of ACTH(4-10). Registered in Russia for stroke and cognitive indications; Western research-use only.

Chemistry quick-facts

CAS
80714-61-0
Formula
C37H51N9O10S
MW
813.94 Da
Length
7 aa
Status
Registered for clinical use in Russia for cognitive and neuroprotective indications. No Western regulatory approval.
Purity (HPLC)
≥ 99.0%

Mechanism of action

Proposed: BDNF / NGF modulation, melanocortin-receptor binding, neuroprotective signalling in preclinical ischaemia models.

Research context

Semax is a synthetic heptapeptide developed at the Institute of Molecular Genetics in Moscow. It comprises residues 4-7 of ACTH followed by the C-terminal Pro-Gly-Pro tripeptide, enhancing enzymatic stability.

Registered in the Russian Federation for ischaemic stroke and cognitive-enhancement indications; not approved in the EU, UK, US, or other Western jurisdictions.

Published studies

A non-exhaustive list of peer-reviewed studies referenced when curating this entry. Click through to the primary source for the full text.

  1. Dolotov OV, Karpenko EA, Inozemtseva LS, et al. (2006). Semax, an analogue of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research.

Reconstitution

Solvent
Bacteriostatic water for injection (0.9% benzyl alcohol) — included with kit
Typical volume
1 – 2 mL
  • · Inject diluent slowly down the side of the vial onto the cake.
  • · Swirl gently — do not shake.
  • · Solution should be clear and colourless. Discard if not.

Storage

Lyophilised
−20 °C, desiccated, protected from light. Stable at 15–25 °C for up to 30 days in transit.
Reconstituted
2–8 °C, original vial, consumed within 4 weeks.
Shelf life — sealed
24 months from date of manufacture when stored lyophilised at −20 °C.

FAQ

Where is Semax approved?+

In the Russian Federation only, for specific cognitive and ischaemic-stroke indications. Not approved in the UK, EU, US, or most other jurisdictions.

Research-use disclaimer

This page summarises the research literature on Semax 11 mg for in vitro laboratory investigation only. It is not medical advice, not a treatment recommendation, and not a substitute for a qualified physician. Material is sold for analytical chemistry and cell-culture research, not for human or veterinary administration.

View Semax 11 mg in the catalogue →
§ Related reading